The U.S. Food and Drug Administration (FDA) has released a statement regarding Chronic Cerebrospinal Venous Insufficiency (CCSVI) Treatment for Multiple Sclerosis also known as the "Liberation Procedure."  For patients who have expressed interest in CCSVI, please read their statement in the link below.  Your physicians at the IMSMP support the recommendations stated by the FDA.http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm303318.htm?....